AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05216939 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flannel mask with ties
Description: Participants will have a mask fit test and will wear a flannel mask with ties. While wearing the flannel mask, participants will perform a sequence of activities. The researchers will note whether the mask lost its fit (e.g., slipping off the nose or face). Between activities, participants will be told to re-adjust the mask. Participants will be assigned to a specific speed on a treadmill with no incline, either 1.5 mph, the 'light' activity level, or 3 mph, the 'moderate' activity level. They will walk on the treadmill for 10 minutes. Prior to the treadmill activity, participants will rate the comfort of the mask. Near the end of the activity, participants will rate their perceived exertion and again rate the comfort of the mask. Participants will complete a post-experiment questionnaire following all activities.
Study NCT05216939 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Twill mask with ear loops
Description: Participants will have a mask fit test and will wear a twill mask with ear loops. While wearing the twill mask with ear loops, participants will perform a sequence of activities. The researchers will note whether the mask lost its fit (e.g., slipping off the nose or face). Between activities, participants will be told to re-adjust the mask. Participants will be assigned to a specific speed on a treadmill with no incline, either 1.5 mph, the 'light' activity level, or 3 mph, the 'moderate' activity level. They will walk on the treadmill for 10 minutes. Prior to the treadmill activity, participants will rate the comfort of the mask. Near the end of the activity, participants will rate their perceived exertion and again rate the comfort of the mask. Participants will complete a post-experiment questionnaire following all activities.
Study NCT05216939 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Twill mask with ties
Description: Participants will have a mask fit test and will wear a twill mask with ties. While wearing the twill mask with ties, participants will perform a sequence of activities. The researchers will note whether the mask lost its fit (e.g., slipping off the nose or face). Between activities, participants will be told to re-adjust the mask. Participants will be assigned to a specific speed on a treadmill with no incline, either 1.5 mph, the 'light' activity level, or 3 mph, the 'moderate' activity level. They will walk on the treadmill for 10 minutes. Prior to the treadmill activity, participants will rate the comfort of the mask. Near the end of the activity, participants will rate their perceived exertion and again rate the comfort of the mask. Participants will complete a post-experiment questionnaire following all activities.
Study NCT05013021 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sprint Interval Training
Description: The Sprint Interval Training (SIT) training consists of 3 successive blocks of 5 training sessions each. The sessions are 24 to 48 hours apart.~. One block lasts two weeks. After the end of one block, the following block begins the day after.~The Sprint Interval Training lasts 6 weeks.~Each session consists of a series of sprints, the number of which varies from 8 to 14. Thus a session will last from 30 to 45 min approximately~So, the time frame of this study is Baseline, Block 1, Block 2 and Block 3 (Not in day or week or month)
Study NCT05376527 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Double Recombinant Vaccinia Virus VV-GMCSF-Lact
Description: Intratumoral injections:~1\*107 PFU (calculated at minimal ED on mice); 2\*107 PFU; 4\*107 PFU; 6\*107 PFU; 8\*107 PFU; 10\*107 PFU;
Study NCT04584931 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: coronally advanced flap
Description: flap surgery to achieve root coverage at gingival recession defect
Study NCT04584931 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: restorative intervention
Description: colored composite restoration to camouflage the gingival recession defect
Study NCT05013697 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel + Cisplatin + TQB2450 injection+ Anlotinib
Description: TQB2450 injection: 1200 mg, i.v.gtt , d1;Anlotinib 10mg, po.qd , d1-14；Paclitaxel 135mg/m2, i.v.gtt , d1; Cisplatin 60-75mg/m2, i.v.gtt , d1-d3; The above schemes are repeated every three weeks. After 4-6 cycles, the regimen is changed to Anlotinib (10mg, po.qd , d1-14)+TQB2450 injection（1200 mg, i.v.gtt , d1）. The regimen is repeated every 3 weeks until the disease progresses.
Study NCT05013697 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel + Cisplatin + TQB2450 injection
Description: TQB2450 injection: 1200 mg, i.v.gtt , d1;Paclitaxel 135mg/m2, i.v.gtt , d1; Cisplatin 60-75mg/m2, i.v.gtt , d1-d3; The above schemes are repeated every three weeks. After 4-6 cycles, the regimen is changed to TQB2450 injection（1200 mg, i.v.gtt , d1）. The regimen is repeated every 3 weeks until the disease progresses.
Study NCT06074549 — intervention group
Intervention type: DEVICE
Intervention: DynamX Novolimus-eluting Coronary Bioadaptor System
Description: All patients will receive at least one DynamX Bioadaptor implant in a commercial setting in accordance with the product's Instructions for Use
Study NCT05070312 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MEDI3506
Description: MEDI3506
Study NCT05070312 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05776615 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mobile application
Description: In the collection of Mobile Application group data, they will be asked to fill out the forms.The mobile application will be introduced, the application will be downloaded from the virtual market (Google Play Store or App Store) to the phone, login will be provided by giving a user name and password, and how to use the application will be explained. Participants will be asked to provide nursing care using this application once a week for 3 months.Nursing Diagnosis Perception Scale with nurses at the end of the 1st month and at the end of the 3rd month;  MıssCare Questionnaire in the Neonatal Intensive Care Unit(NICU); System Availability Scale will be applied.
Study NCT04741282 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary telerehabilitation
Description: pulmonary telerehabilitation program include breathing exercise,aerobics exercise and upper and lower limbs muscle strengthening exercise
Study NCT04741282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary telerehabilitation
Description: pulmonary telerehabilitation program include breathing exercise,aerobics exercise and upper and lower limbs muscle strengthening exercise
Study NCT04741282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: progressive muscle relaxation training
Description: summarized Jacobson progressive muscle relaxation training method
Study NCT04008576 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Group Blended Transdiagnostic treatment
Description: The treatment combines group face-to-face and Internet-delivered psychotherapy: 7 group sessions delivered every 3 weeks plus the use of an online treatment platform between sessions. Its goal is to learn and practice adaptive regulation strategies from a mechanistically transdiagnostic approach, with a focus on both negative and positive affectivity. Each group session will focus on one of the following core components: the first group session will focus on CBT traditional strategies such as motivation for change and psychoeducation about emotions; sessions 2 to 5 will focus on strategies to down-regulate negative affect: present-focused emotional awareness, cognitive flexibility, emotional avoidance and emotion-driven behaviors, and interoceptive and situation-based emotion exposure; session 6 will focus on strategies to regulate positive affect; the final session will teach relapse prevention techniques. All the treatment components are delivered in 16 online treatment modules.
Study NCT05454098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clifutinib with fed state
Description: 40 mg Clifutinib with food
Study NCT05454098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clifutinib with fasted state
Description: 40 mg Clifutinib without food
Study NCT05504031 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hybrid coronary revascularization
Description: Coronary revascularization is conducted as a combined MIDCAB (LIMA-LAD grafting through a minimally invasive anterior left thoracotomy) and PCI (of all non-LAD stenoses)
Study NCT05504031 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional revascularization
Description: Conventional revascularization with CABG of all significant stenoses through a sternotomy
Study NCT05239156 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Janesse
Description: Device: Janesse® is a sterile, injectable, non-pyrogenic, re-absorbable medical product made of reticulated hyaluronic acid of non-animal origin, produced via bacterial fermentation.~The subjects will receive at baseline the first investigational medical device by the Investigator in accordance with the clinical investigation plan.
Study NCT04938752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-2811
Description: single dose administration (one tablet once a day)
Study NCT04938752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-2811-R
Description: single dose administration (one tablet once a day)
Study NCT05837325 — intervention group
Intervention type: PROCEDURE
Intervention: Oocyte Pick Up - Out of Study
Description: Aspiration of follicles. search for the oocyte(s) All oocytes are grouped in one dish.
Study NCT05837325 — intervention group
Intervention type: PROCEDURE
Intervention: Denudation - Out of Study
Description: All oocytes are denuded together. Maturational stages are recorded.
Study NCT05837325 — intervention group
Intervention type: PROCEDURE
Intervention: ICSI
Description: One oocyte injected at a time.
Study NCT05837325 — intervention group
Intervention type: PROCEDURE
Intervention: Culture
Description: One embryo per culture drop. Individual follow-up of the embryo development.
Study NCT05837325 — intervention group
Intervention type: GENETIC
Intervention: Biopsy
Description: One embryo per culture drop.
Study NCT05837325 — intervention group
Intervention type: PROCEDURE
Intervention: Vitrification
Description: One embryo per vitrification straw.
Study NCT05837325 — intervention group
Intervention type: PROCEDURE
Intervention: OPU - Study Group
Description: Measure the size of the follicle and aspirate only one follicle and flush. The needle before moving to the second ovary. Oocyte included in the study will be cultured separately (each ovary separately too).
Study NCT05837325 — intervention group
Intervention type: PROCEDURE
Intervention: Denudation - Study Group
Description: Oocyte included in the study will be denuded separately. Maturational stages are recorded per follicle.
Study NCT04396288 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ultrasound imaging at the forearm and at the tibia
Description: ultrasound imaging will be performed at the radius bone (forearm) and at the tibia, before, during, and after a change of intraosseous blood flow
Study NCT06117033 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: video assisted mobilization training
Description: Preoperative video-assisted mobilization training was given to patients undergoing coronary artery bypass graft surgery
Study NCT06137885 — intervention group
Intervention type: BEHAVIORAL
Intervention: Cardiac rehabilitation
Description: Cardiac rehabilitation is a comprehensive model of care involving prescribed exercise, medication management, lifestyle modification, and psychosocial counseling to help people with heart diseases resume and enhance their psychosocial and vocational status.
Study NCT06137885 — intervention group
Intervention type: OTHER
Intervention: Active post-market surveillance of devices
Description: Active post-market surveillance of devices is an essential and ongoing process that involves systematic monitoring and assessment of medical devices once they are available on the market. It involves continuous data collection and analysis, early detection of issues, risk assessment, compliance with regulatory requirements, adaptive decision-making, and transparent communication with healthcare professionals and patients.
Study NCT06137885 — intervention group
Intervention type: OTHER
Intervention: Multi-omics approach to precision medicine
Description: Multi-omics analysis refers to the collective analysis of extensive biological data from multiple omics sources to gain a holistic understanding of an individual's health status, disease susceptibility, and response to therapies. By considering a broad spectrum of genetic and molecular information, multi-omics precision medicine aims to deliver more accurate diagnoses, predict disease risks, select optimal treatment options, and monitor therapeutic responses with a high degree of specificity, ultimately improving patient outcomes and minimizing adverse effects.
Study NCT06137885 — intervention group
Intervention type: OTHER
Intervention: The prescription pattern analysis
Description: The prescription pattern analysis refers to the systematic examination and evaluation of the types, dosages, frequencies, and trends in medications prescribed to patients with cardiovascular conditions. By scrutinizing prescription patterns, researchers and healthcare professionals can identify prevalent medications, assess adherence to treatment guidelines, uncover potential gaps or areas for improvement in patient care, and gain insights into the evolving landscape of cardiovascular therapies.
Study NCT05986825 — intervention group
Intervention type: OTHER
Intervention: Verneuil questionnaire Validation
Description: Request patient to Complete the questionnaire for validation of the French version
Study NCT06229483 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION
Description: Tranexamic acid 20 mg/kg IV bolus within 30 minutes prior to the skin incision followed by a 1 mg/kg/hr infusion of TXA, for the duration of surgery. Treatment is blinded.
Study NCT06229483 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% normal saline 20ml/kg IV bolus within 30 minutes prior to the skin incision followed by a 1 ml/kg/hr infusion of 0.9 % sodium chloride for the duration of surgery. Treatment is blinded.
Study NCT04863313 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: Experimental group will consume one probiotic capsule every day during 12 weeks at breakfast.
Study NCT04863313 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo group will consume one placebo capsule every day during 12 weeks at breakfast.
Study NCT05709314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMDX-2011P
Description: AMDX-2011P single bolus injection intravenous for diagnostic review
Study NCT05304286 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Acceptance and Commitment Therapy
Description: The aim of ACT is to address avoidance behaviors by increasing openness to difficult experiences, such as pain, and to develop an awareness of behavioral options that will aid to facilitate behavior change processes that are in accord with living a values-based life.
Study NCT05731791 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy to partial breast
Description: Patients randomized to ARM 1 will receive 3000 cGy in 5 fractions partial breast radiotherapy with CT-based breast radiation treatment (Arm 1) and patients randomized to ARM 2 will receive 3000 cGy in 5 fractions partial breast radiotherapy with MRI-based breast radiation treatment (Arm 2).
Study NCT06273826 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Colorectal Leakage App
Description: The Colorectal Leakage App is a mobile application designed to aid in the early detection of anastomotic insufficiency after colorectal surgeries. The app is based on the Dutch Leakage Score (DLS) algorithm, which is a standardized protocol for postoperative monitoring.
Study NCT06300671 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Foot Posture Index-6
Description: Foot Posture Index 6 (API-6) is a clinical diagnostic tool that broadly measures whether a foot is in neutral, supination or pronation posture. During the evaluation, individuals' static standing postures in a comfortable position are observed and scored. When using API-6, researchers visually evaluate the foot according to 6 criteria, each rated on a 5-point (-2 to +2) Likert scale. Each item is scored between -2 (supination) and +2 (pronation) and 0 (for neutral position), with the total score being between -12 (high degree of supination) and +12 (high degree of pronation). The grouping of reference values showing foot posture can be summarized as follows; Neutral position from 0 to +5, pronation position from +6 to +9, hyperpronation position from +10 to +12, supination position from -1 to -5, and supination position from -6. It shows a high degree of supination position up to -12. Higher scores represent a more pronated foot posture.
Study NCT06483139 — intervention group
Intervention type: PROCEDURE
Intervention: Plasma exchange
Description: Patients treated with plasma exchange within 30 days of diagnosis of light chain cast nephropathy Patients not treated with daratumumab within 30 days of diagnosis of light chain cast nephropathy
Study NCT06483139 — intervention group
Intervention type: DRUG
Intervention: Daratumumab
Description: Patients treated with daratumumab within 30 days of diagnosis of light chain cast nephropathy
Study NCT06387485 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D Printed Anatomic Model
Description: Patient-specific 3D printed anatomic model for pre-surgical planning
Study NCT06387485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CT/MRI
Description: Standard imaging type for bony tumors
Study NCT06387485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: CT/MRI
Description: Standard imaging type for bony tumors
Study NCT05967052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin
Description: Pregabalin pharmacotherapy
Study NCT05967052 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Independent walking training
Description: Independent walking training
Study NCT05967052 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Independent walking training
Description: Independent walking training
Study NCT05491096 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Training
Description: Proprioceptive exercises will be divided into three components. The first component will be comprised of standing on Foam with eyes open and eyes closed and passing any object from one subject to the other for 10 minutes. The second component consists of activity that will be performed in groups of two. Throwing and catching a ball will be performed while standing on foam for additional10 minutes. The third component, throwing and catching a ball, will be performed on trampoline to further challenge the balance system. After each set of 10-minute exercise, the subjects will be given two-minute resting periods. In the end, 10 minutes will be given for cooling down in which deep breathing exercises and static back extensor stretching exercises will be performed to avoid fatigue and to bring the heart rate back to the normal resting level.
Study NCT05491096 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Conventional Physical Therapy
Description: Conventional treatment protocolconsists of a structured exercise protocol Each training session consisted of three parts, the first part included the main movements (warming up 10 minutes plus 5 minutes stretching exercises), the second part consisted of specific movements (exercises with theraband and physioball, 20 minutes), and the third part composed of cool down exercises (10 minutes).(22)Experimental treatment protocolwill be proprioceptive training program. PTP will be based on earlier studies, and will be carried out for eight weeks, with two 60-minute sessions per week. It will start with 10 minutes of Warm-up activities when the subjects will be advised to do light manual stretches and to step up and down on foam to get their body warmed up to have improve muscular flexibility. This will be followed by 30 minutes of proprioceptive exercises targeting lower extremities.
Study NCT05597540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Short antibiotic treatment
Description: 7 day-duration antibiotic treatment. The choice of antibiotic treatment is left to the medical team in charge of the patient.
Study NCT05597540 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Usual antibiotic treatment
Description: 14 day-duration antibiotic treatment. The choice of antibiotic treatment is left to the medical team in charge of the patient.
Study NCT06502145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine Level -1
Description: Intravenous (IV) or subcutaneous (SC) 75 mg / m\^2 days 1-7 X 28 days.
Study NCT06502145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine Level 0
Description: Intravenous (IV) or subcutaneous (SC) 75 mg / m\^2 days 1-7 X 28 days.
Study NCT06502145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine Level 1
Description: Intravenous (IV) or subcutaneous (SC) 75 mg / m\^2 days 1-7 X 28 days.
Study NCT06502145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iadademstat Level -1
Description: 75 µg by mouth (PO) 5 days on, 2 days off for 2 weeks every 28 days.
Study NCT06502145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iadademstat Level 0
Description: 75 µg PO 5 days on, 2 days off for 3 weeks every 28 days.
Study NCT05967052 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06502145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iadademstat Level 1
Description: 100 µg PO 5 days on, 2 days off for 3 weeks every 28 days.